文献速递性腺与生殖内分泌

睾酮、双氢睾酮与雌二醇水平变化与睾酮试验中结局指标变化的关系

Relation of Testosterone, Dihydrotestosterone, and Estradiol With Changes in Outcomes Measures in the Testosterone Trials.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

基于睾酮试验数据,评估老年性腺功能减退男性经12个月睾酮治疗后总睾酮、雌二醇和双氢睾酮变化与血红蛋白、高密度脂蛋白胆固醇、腰椎体积骨密度、性欲和前列腺特异性抗原的关联。随机森林模型显示雌二醇变化是上述多数结局的最佳预测指标,联合三种激素预测治疗反应优于单用睾酮。

要点

  • 雌二醇变化是腰椎体积骨密度和性欲变化的最佳预测指标。
  • 雌二醇变化也与血红蛋白升高和高密度脂蛋白胆固醇降低相关。
  • 联合睾酮、雌二醇和双氢睾酮预测治疗反应优于单用睾酮。

核心结论

  • 雌二醇水平变化不仅是体积骨密度和性欲变化的最佳预测指标,也是血红蛋白和高密度脂蛋白胆固醇变化的最佳预测指标。
  • 联合考虑睾酮、雌二醇和双氢睾酮对老年性腺功能减退男性治疗反应的预测优于单用睾酮。

研究设计与样本

  • 使用睾酮试验数据,评估12个月睾酮治疗期间总睾酮、雌二醇和双氢睾酮水平变化与血红蛋白、高密度脂蛋白胆固醇、腰椎体积骨密度、性欲和前列腺特异性抗原的关联。
  • 采用随机森林模型模拟在另外两种激素低、中或高变化时,每个激素变化与结局预测均值变化的关联,并用逐步回归模型确认随机森林的发现。

主要发现

  • 雌二醇增加越大,血红蛋白和性欲的预测增加越大,且双氢睾酮高变化时比低变化时更大。
  • 雌二醇增加越大与高密度脂蛋白胆固醇降低越大相关,该关联不随双氢睾酮或睾酮变化而改变。
  • 体积骨密度变化与雌二醇变化关联最稳健,且在睾酮和双氢睾酮高变化时更大。
  • 前列腺特异性抗原变化与任何激素变化之间无一致关系。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Many effects of testosterone are mediated through dihydrotestosterone (DHT) and estradiol. OBJECTIVE: To determine the relative contributions of each hormone to the observed effects of testosterone treatment in older men with hypogonadism. METHODS: Using data from the Testosterone Trials, we assessed the association of changes in total testosterone, estradiol, and DHT levels over 12 months of testosterone treatment with hemoglobin, high-density lipoprotein (HDL) cholesterol, volumetric bone mineral density (vBMD) of lumbar spine, sexual desire, and prostate-specific antigen (PSA). We used random forests to model the associations of predicted mean changes in outcomes with change in each hormone at low, mean, or high change in the other 2 hormones. Stepwise regression models were run to confirm the findings of random forests. RESULT: Predicted increases in hemoglobin and sexual desire were greater with larger increases in estradiol and were larger with high change in DHT compared with low change in DHT. Greater increases in estradiol were associated with larger decreases in HDL cholesterol; this association did not vary according to changes in DHT or testosterone. Change in vBMD was most robustly associated with change in estradiol and was greater with high change in testosterone and DHT. There was no consistent relation between change in PSA and change in any hormone. CONCLUSION: Change in estradiol level was the best predictor not only of the change in vBMD and sexual desire but also of the changes in hemoglobin and HDL cholesterol. Consideration of testosterone, estradiol, and DHT together offers a superior prediction of treatment response in older hypogonadal men than testosterone alone.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Stephens-Shields AJ, Snyder PJ, Ellenberg SS, et al. Relation of Testosterone, Dihydrotestosterone, and Estradiol With Changes in Outcomes Measures in the Testosterone Trials. J Clin Endocrinol Metab. 2022. PMID: 35041751. doi:10.1210/clinem/dgac028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。